Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Henry Ford Hosp. CRS
mi
from
Detroit, MI
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Cooper Univ. Hosp. CRS
mi
from
Camden, NJ
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
New Jersey Medical School- Adult Clinical Research Ctr. CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Bronx-Lebanon Hosp. Ctr. CRS
mi
from
Bronx, NY
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Bronx-Lebanon Hosp. Ctr. CRS
mi
from
Bronx, NY
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Cornell CRS
mi
from
New York, NY
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Cornell CRS
mi
from
New York, NY
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
NY Univ. HIV/AIDS CRS
mi
from
New York, NY
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
HIV Prevention & Treatment CRS
mi
from
New York, NY
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
HIV Prevention & Treatment CRS
mi
from
New York, NY
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Univ. of Rochester ACTG CRS
mi
from
Rochester, NY
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Chapel Hill CRS
mi
from
Chapel Hill, NC
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Duke Univ. Med. Ctr. Adult CRS
mi
from
Durham, NC
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Greensboro CRS
mi
from
Greensboro, NC
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Greensboro CRS
mi
from
Greensboro, NC
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Univ. of Cincinnati CRS
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Case CRS
mi
from
Cleveland, OH
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Case CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
MetroHealth CRS
mi
from
Cleveland, OH
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
MetroHealth CRS
mi
from
Cleveland, OH
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Hosp. of the Univ. of Pennsylvania CRS
mi
from
Philadelphia, PA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Hosp. of the Univ. of Pennsylvania CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Thomas Jefferson Univ. Med. Ctr. CRS
mi
from
Philadelphia, PA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Thomas Jefferson Univ. Med. Ctr. CRS
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Pitt CRS
mi
from
Pittsburgh, PA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Pitt CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
The Miriam Hosp. ACTG CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Vanderbilt Therapeutics CRS
mi
from
Nashville, TN
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Vanderbilt Therapeutics CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
University of Washington AIDS CRS
mi
from
Seattle, WA
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
University of Washington AIDS CRS
mi
from
Seattle, WA
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated:  1/8/2018
Washington U CRS
mi
from
Saint Louis, MO
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Washington U CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated:  1/8/2018
Alabama CRS
mi
from
Birmingham, AL
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated: 1/8/2018
Alabama CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated:  1/8/2018
Ponce de Leon CRS
mi
from
Atlanta, GA
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated: 1/8/2018
Ponce de Leon CRS
mi
from
Atlanta, GA
Click here to add this to my saved trials
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated:  1/8/2018
Johns Hopkins Baltimore CRS
mi
from
Baltimore, MD
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated: 1/8/2018
Johns Hopkins Baltimore CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated:  1/8/2018
Fenway Health CRS
mi
from
Boston, MA
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States
Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex With Men (MSM) in the United States
Status: Enrolling
Updated: 1/8/2018
Fenway Health CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Alabama CRS
mi
from
Birmingham, AL
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Alabama CRS
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
University of Southern California CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
UCLA CARE Center CRS
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
UCSD Antiviral Research Center CRS
mi
from
San Diego, CA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Ucsf Hiv/Aids Crs
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Harbor-UCLA CRS
mi
from
Torrance, CA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Harbor-UCLA CRS
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
University of Colorado Hospital CRS
mi
from
Aurora, CO
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
University of Colorado Hospital CRS
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Northwestern University CRS
mi
from
Chicago, IL
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Northwestern University CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Johns Hopkins University CRS
mi
from
Baltimore, MD
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Johns Hopkins University CRS
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
mi
from
Boston, MA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
New Jersey Medical School Clinical Research Center CRS
mi
from
Newark, NJ
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Chapel Hill CRS
mi
from
Chapel Hill, NC
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Chapel Hill CRS
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Greensboro CRS
mi
from
Greensboro, NC
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Greensboro CRS
mi
from
Greensboro, NC
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Cincinnati Clinical Research Site
mi
from
Cincinnati, OH
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Cincinnati Clinical Research Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Case Clinical Research Site
mi
from
Cleveland, OH
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Case Clinical Research Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Ohio State University CRS
mi
from
Columbus, OH
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Ohio State University CRS
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Penn Therapeutics Crs
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
University of Pittsburgh CRS
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
mi
from
Providence, RI
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
The Miriam Hospital Clinical Research Site (TMH CRS) CRS
mi
from
Providence, RI
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Vanderbilt Therapeutics (VT) CRS
mi
from
Nashville, TN
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Houston AIDS Research Team CRS
mi
from
Houston, TX
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Houston AIDS Research Team CRS
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated:  1/9/2018
Washington University Therapeutics (WT) CRS
mi
from
Saint Louis, MO
Safety and Effectiveness of Low-Dose Methotrexate for Reducing Inflammation in HIV-Infected Adults on ARV Medications
Effect of Reducing Inflammation With Low Dose Methotrexate on Inflammatory Markers and Endothelial Function in Treated and Suppressed HIV Infection
Status: Enrolling
Updated: 1/9/2018
Washington University Therapeutics (WT) CRS
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Selective Exposure in HIV Prevention
Study to Test Meta-intervention to Increase Retention in HIV Prevention Counseling
Status: Enrolling
Updated:  1/12/2018
Duval County Health Department
mi
from
Jacksonville, FL
Selective Exposure in HIV Prevention
Study to Test Meta-intervention to Increase Retention in HIV Prevention Counseling
Status: Enrolling
Updated: 1/12/2018
Duval County Health Department
mi
from
Jacksonville, FL
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials